NCT05939921View on ClinicalTrials.gov

Effects of Metformin Therapy on Pancreatic and Hepatic Fat Content in Patients of Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

June 30, 2023

Conditions
Type2diabetes
Interventions
DRUG

Metformin

T2DM patients will be provided with metformin in a specified dose

Trial Locations (1)

110048

Anoop misra, New Delhi

All Listed Sponsors
collaborator

National Diabetes Obesity and Cholesterol Foundation

OTHER

lead

Diabetes Foundation, India

OTHER